Publication | Closed Access

Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease

PathologyFatty Liver DiseaseOxidative StressInflammationMetabolic SyndromeNonalcoholic Fatty Liver DiseaseHepatotoxicityAtherosclerosisInflammatory BiomarkersHealth SciencesMetabolic Associated SteatohepatitisLiver PhysiologyResveratrol SupplementationHepatology InflammationMetabolomicsPharmacologyDrug-induced Liver InjuryHepatologyLiver DiseaseMedicine